about
Antibiotics for secondary prevention of coronary heart diseaseUnexpected protective role for Toll-like receptor 3 in the arterial wallAssociation of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review.Multiple Infectious Agents and the Origins of Atherosclerotic Coronary Artery DiseaseBacterial invasion of vascular cell types: vascular infectology and atherogenesis.The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequencesResistant pathogens, fungi, and viruses.Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.Chlamydia pneumoniae and coronary heart disease.Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium.Inflammation, the acute phase response and atherosclerosis.Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression.Decreased messenger RNA translation in herpesvirus-infected arterial cells: effects on cholesteryl ester hydrolaseHumoral immune response to human cytomegalovirus in patients undergoing percutaneous transluminal coronary angioplastyCytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.Lessons for atherosclerosis research from tuberculosis and peptic ulcer.Microbes, inflammation and atherosclerosis: will old pathology lessons guide new therapies?Cytomegalovirus infection and cardiac allograft vasculopathy.Inflammation, infection and antimicrobial therapy in coronary heart disease--where do we currently stand?Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus.Is periodontitis associated with an increased risk of coronary heart disease and preterm and/or low birth weight births?Herpes virus infection of endothelium: new insights into atherosclerosisInfluenza and cardiovascular disease: is there a causal relationship?The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virusCytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells.Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathyInfrequency of cytomegalovirus genome in coronary arteriopathy of human heart allograftsCharacterization of human aortic smooth muscle cells expressing HPV16 E6 and E7 open reading frames.Transformation of rabbit vascular smooth muscle cells by transfection with the early region of SV40 DNACardiovascular lipid accumulation with Coxsackie B virus infection in miceHerpesviridae in the coronary arteries and aorta of young trauma victimsLinking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model.Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genesVirus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulationAtherosclerosis following balloon catheter injury to the carotid artery and the aorta of hypertensive rats with normolipidemia or hyperlipidemia.Herpesvirus infection enhances cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cellsInfection and Atherosclerosis DevelopmentInfluenza and atherosclerosis: vaccination for cardiovascular disease prevention.Role of endothelium and hypercholesterolemia in intimal thickening and lipid accumulation.Atheroarteriosclerosis induced by infection with a herpesvirus
P2860
Q24201388-819A8340-0347-45D5-9B13-64DFD2EC7B7BQ24624935-1ADB7A0D-499D-4AFB-887A-5EE26A58E65DQ24791856-1331DB1C-B99D-4BEB-B5DF-71F192F15BA7Q27330093-3C8C7E0C-D5C1-4C64-BCEF-A5D160BEFDF0Q27692034-4905C6F0-26AF-4A41-94FA-17EA4C64A470Q28188518-765E1A5A-BFF8-4B8E-AB23-D9DBD33B6DCDQ30301237-C85F7E56-3B04-4C26-996A-B3BB1A5DC7EEQ33306319-0F873CB1-32C1-4AAB-9383-0B02E73B3C1AQ33659387-01596373-F5BE-48DF-8A0C-D10B45CC1506Q33665374-1460CEF1-BF55-4586-AC15-987D33FD99EFQ33694694-58EFF554-E40A-4464-B826-6817B997A65CQ33791628-57169797-FD45-4B77-8292-E84CDF1C2030Q33854609-AA00C03B-8DB5-42D8-AF8C-9F9419143E54Q33997521-B154FAC7-4F35-4F23-8086-1E7817D2343FQ34169756-55EC6F4C-8F71-4A83-AA9A-543A9B990C83Q34278447-D89057A0-17B2-47E4-988D-C3345811DED7Q34286610-F2295FD9-71A7-412C-ABF7-AA098B190D76Q34294809-9FB0949D-F304-4406-A58A-4CF1DE59EE1BQ34316462-70300F73-A276-40AA-BCEC-6B288E07914EQ34605079-36A15719-E22F-4DF4-A2BA-4A060CFC5D89Q35145332-3C3B3E36-7DE3-44AE-A390-D69FB02CA682Q35234479-A37A4E05-C8E0-406A-ABF5-AACDA5D4DA42Q35733937-FC86EB2B-DDDC-42DE-BE3F-ED8E5639AF4BQ35760645-CB8B897D-BA86-4208-89EA-1AB812763592Q35782519-3AE8A9A9-8483-4353-AAE7-28983F5D478BQ35796013-203F48C4-E0A5-4597-B265-40EA5474459CQ35796129-39318E03-CD7A-41B2-9440-B8F79EEF3D0FQ35798441-198863D3-1795-4CD1-9C74-D01F7FCF9E86Q35811203-9910C531-C00A-40BD-9A7C-6322736B5215Q35811360-F43C5C34-389A-4161-9899-1286BAB23B6DQ35818356-F3162F67-2C90-409C-B862-B304A461C465Q35824235-8B6867B8-8F46-4E29-8EF6-3211E92B8ABBQ35831484-16D0AE45-5DFB-4D94-A6E2-3309587C01B5Q35835744-54457A46-68A7-444B-8B2F-A2E242CF19C7Q35864059-698D6D9A-958E-4B48-8E87-3D238538B111Q35864249-7A43F79B-5FA3-4C5F-BE5D-1295337A4156Q35915081-0830422A-30E9-4F6E-B76B-5D83ED18411DQ36040828-F9C022F1-D9C2-47F6-99B3-B0AEB5D7DA48Q36092879-FA7B7474-7BA8-48AC-9ECE-4B5A0495B069Q36093155-3596B99D-B049-426A-875C-B7C134143065
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Virus-induced atherosclerosis.
@ast
Virus-induced atherosclerosis.
@en
type
label
Virus-induced atherosclerosis.
@ast
Virus-induced atherosclerosis.
@en
prefLabel
Virus-induced atherosclerosis.
@ast
Virus-induced atherosclerosis.
@en
P2093
P2860
P356
P1476
Virus-induced atherosclerosis.
@en
P2093
Fabricant CG
Fabricant J
Litrenta MM
P2860
P304
P356
10.1084/JEM.148.1.335
P407
P577
1978-07-01T00:00:00Z